Post by CPTx

𝗖𝗣𝗧𝘅 𝗮𝗽𝗽𝗼𝗶𝗻𝘁𝘀 𝗘𝗱𝘄𝗮𝗿𝗱 𝗥𝗲𝗯𝗮𝗿 𝗮𝘀 𝗖𝗵𝗶𝗲𝗳 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝗳𝗶𝗰 𝗢𝗳𝗳𝗶𝗰𝗲𝗿! We are excited to welcome Edward Rebar as Chief Scientific Officer (CSO) to our executive team! Edward will focus on translating our vector technology and scientific innovation into therapeutic leads. “Ed brings extensive experience in gene therapies, including gene editing, and in the development of new genetic medicines,” says our CEO Hendrik Dietz. Read more via the link in the comments! #CPTx #CSO #ssDNA #invivo #CART #GeneTherapy #CellTherapy #PrecisionMedicine